Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Helmerich & Payne Inc. Common Stock (HP) vs IQVIA Holdings Inc. Common Stock (IQV) Price & Performance

Helmerich & Payne Inc. Common StockTrade
IQVIA Holdings Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Helmerich & Payne Inc. Common Stock vs IQVIA Holdings Inc. Common Stock — how do they compare? Helmerich & Payne Inc. Common Stock trades at $38.46 (market cap $3.91B), while IQVIA Holdings Inc. Common Stock trades at $261.7 (market cap $42.91B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 11× Helmerich & Payne Inc. Common Stock's market cap, and Helmerich & Payne Inc. Common Stock pays a 2.56% dividend while IQVIA Holdings Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Helmerich & Payne Inc. Common Stock for 0 Days and IQVIA Holdings Inc. Common Stock for 6 Days on average.

HPIQV
Market Cap
$3.91B$42.91B
Volume
800,3821,333,456
Sector
EnergyHealth
52-Week High
$47.64$275.02
52-Week Low
$23.11$156.66
Typical Hold Time
0 Days6 Days
Enterprise Value
$5.54B$57.07B
Dividend Yield
2.56%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Helmerich & Payne Inc. Common Stock

No Aura AI signal available yet.

IQVIA Holdings Inc. Common Stock

IQVIA Holdings (IQV) trades at $260.71, down 0.57% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $284.64. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $3.15 surpassing the $3.03 estimate. Revenue growth is steady, projected at $17.0B for 2026, while profitability metrics like a 23.01% ROE and 8.1% net income margin reflect operational strength. The company continues to innovate, launching new predictive analytics tools for life sciences clients.

The outlook for IQV remains positive, supported by strong earnings performance and analyst optimism, though investors should note valuation multiples above sector averages and debt levels. Key risks include competitive pressures in clinical research services and macroeconomic sensitivity affecting client spending.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HP
100% Buy0% Sell
Avg holding period · 0 Days
IQV

No sentiment data available yet.

About Helmerich & Payne Inc. Common Stock

Helmerich & Payne, Inc. is a US drilling contractor that designs, builds, and operates high-performance land and offshore drilling rigs for oil and gas producers worldwide.

Read more on HP →

About IQVIA Holdings Inc. Common Stock

IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.

Read more on IQV →